DRAVP ID Name Sequence Target Organism Pubmed/Patent ID
DRAVPe01493 GBVA7(4-23) CWVRLGRYLLRRLKTPFTRL HCV 23175359
DRAVPe01494 GBVA8(2-19) LDCWVRLGRYLLRRLKTP HCV 23175359
DRAVPe01495 GBVA9(3-20) DCWVRLGRYLLRRLKTPF HCV 23175359
DRAVPe01496 GBVA10(4-21) CWVRLGRYLLRRLKTPFT HCV 23175359
DRAVPe01497 GBVA11(5-22) WVRLGRYLLRRLKTPFTR HCV 23175359
DRAVPe01498 GBVA12(6-23) VRLGRYLLRRLKTPFTRL HCV 23175359
DRAVPe01499 GBVA10-1(L9K) CWVRLGRYKLRRLKTPFT HCV 23175360
DRAVPe01500 GBVA10-2(L9S) CWVRLGRYSLRRLKTPFT HCV 23175359
DRAVPe01501 GBVA10-3(L9A) CWVRLGRYALRRLKTPFT HCV 23175359
DRAVPe01502 GBVA10-4(L9V) CWVRLGRYVLRRLKTPFT HCV 23175359
DRAVPe01503 GBVA10-5(G6A) CWVRLARYLLRRLKTPFT HCV 23175359
DRAVPe01504 GBVA10-6(G6V) CWVRLVRYLLRRLKTPFT HCV 23175359
DRAVPe01505 GBVA10-7(G6L) CWVRLLRYLLRRLKTPFT HCV 23175359
DRAVPe01506 GBVA10-8(G6L/P16L) CWVRLLRYLLRRLKTLFT HCV 23175359
DRAVPe01507 GBVA10-9(P16L) CWVRLGRYLLRRLKTLFT HCV 23175359
DRAVPe01508 GBVA10-10(L9I) CWVRLGRYILRRLKTPFT HCV 23175359
DRAVPe01509 GBVA10-11(L9I/L13I) CWVRLGRYILRRIKTPFT HCV 23175359
DRAVPe01510 GBVA10-12(L5I/L9I/L13I) CWVRIGRYILRRIKTPFT HCV 23175359
DRAVPe01511 GBVA10-13(C1K/Y8K/T15K/T18K) KWVRLGRKLLRRLKKPFK HCV 23175361
DRAVPe01512 GBVA10-14(C1K/Y8K/T15K) KWVRLGRKLLRRLKKPFT HCV 23175359
DRAVPe01513 GBVA10-15(Y8K/T15K) CWVRLGRKLLRRLKKPFT HCV 23175359
DRAVPe01514 GBVA10-16(Y8K) CWVRLGRKLLRRLKTPFT HCV 23175359
DRAVPe01515 GBVA10-17(C1E/Y8E/T15E) EWVRLGRELLRRLKEPFT HCV 23175359
DRAVPe01516 GBVA10-18(C1E/Y8E/T15E/T18E) EWVRLGRELLRRLKEPFE HCV 23175359
DRAVPe01517 GBVA10-19(Y8E/T15E) CWVRLGRELLRRLKEPFT HCV 23175359
DRAVPe01518 GBVA10-20(Y8E) CWVRLGRELLRRLKTPFT HCV 23175359
DRAVPe01585 NS5A-derived peptide C5A [I6L] SWLRDLWDWICEVLSDFK HCV,HIV 21801309
DRAVPe01586 NS5A-derived peptide C5A [I10L] SWLRDIWDWLCEVLSDFK HCV,HIV 21801309
DRAVPe01587 NS5A-derived peptide C5A [V13L] SWLRDIWDWICELLSDFK HCV,HIV 21801309
DRAVPe01588 NS5A-derived peptide C5A [I6L,I10L] SWLRDLWDWLCEVLSDFK HCV,HIV 21801309
First 7 8 9 10 11 12 13 Last